NYSE · Health Information Services · USD
Phreesia, Inc. (PHR) Stock Analysis
Phreesia, Inc. (PHR) is a Health Information Services stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
PHR Key Statistics
As of Oct 21, 2026Trading
- Open
- $11.99
- Previous Close
- $12.05
- Day's Range
- 11.96–12.54
- 52-Week Range
- 7.77–24.07
- Volume
- 1.02M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.84
Valuation
- Market Cap
- $760.99M
- P/E Ratio
- 72.12
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 7.67
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.50
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.17
Financials (FY)
- Revenue (FY)
- $480.59M+14.48%
- Net Income (FY)
- $2.31M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 2.06%
- Shares Outstanding
- 62.07M
- 1-Year Return
- −46.95%
Dividend and dates
- Avg Volume
- 744.93K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, PHR closed at $12.26, −46.95% over 1 year.
Phreesia, Inc. (PHR) has a market capitalization of $760.99M.
In fiscal 2025, PHR reported revenue of $480.59M.
PHR Stock Return by Calendar Year
Phreesia, Inc. (PHR) return since Jul 2019: what $10,000 became
- 1 year
- $10,000 $5,305
- −46.95%
- 5 years
- $10,000 $1,833
- −81.67%
- Since Jul 2019
- $10,000 $4,888
- −51.12%
If you had invested $10,000 in Phreesia, Inc. (PHR) at the close on July 18, 2019, the earliest close on record here, it would have been worth $4,888 at the close on October 21, 2026: −51.12% in total, −9.39% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −27.54% |
| 2025 | −32.75% |
| 2024 | +8.68% |
| 2023 | −28.46% |
| 2022 | −22.32% |
| 2021 | −23.22% |
| 2020 | +103.68% |
| 2019 (partial year) | +6.22% |
As of October 21, 2026.
PHR Revenue and Earnings by Fiscal Year
FY ends January| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $480.59M | $2.31M | 0.5% |
| 2024 | $419.81M | −$58.53M | −13.9% |
| 2023 | $356.30M | −$136.89M | −38.4% |
| 2022 | $280.91M | −$176.15M | −62.7% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $480.59M | $326.47M | −$6.61M | $2.31M | 0.5% |
| 2024 | $419.81M | $284.88M | −$58.10M | −$58.53M | −13.9% |
| 2023 | $356.30M | $232.29M | −$136.48M | −$136.89M | −38.4% |
| 2022 | $280.91M | $171.64M | −$176.55M | −$176.15M | −62.7% |
Annual figures as reported, in the company's reporting currency. As of January 31, 2026.
PHR Valuation vs Health Information Services Median
Median of 44 stocks| Metric | PHR | Health Information Services median | vs median |
|---|---|---|---|
| P/E | 72.12 | 46.54 | 55% above |
| P/S ratio | 1.50 | 2.31 | 35% below |
| Profit margin | 2.06% | −7.55% | 9.6 pts above |
Medians across 44 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11
BenzingaPhreesia’s Michael Rasbury Named to Becker’s 2026 List of Rising Stars: Healthcare Leaders Under 40
YahooPhreesia to Support Parkinson’s Disease Awareness and Research with The Michael J. Fox Foundation
YahooPhreesia Named to TIME’s 2026 List of the World’s Top HealthTech Companies
YahooWall Street Splits on Phreesia (PHR) as Margins Improve but Growth Visibility Fades
YahooPhreesia’s ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace
Yahoo
All 20 articles ↓Show fewer ↑
Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base
YahooPhreesia (PHR) Q2 2027 Earnings Call Transcript
The Motley FoolWhy Phreesia Stock Got Knocked Down Today
The Motley FoolRaymond James Downgrades Phreesia to Market Perform
BenzingaPhreesia, Inc. 2027 Q2 - Results - Earnings Call Presentation
SeekingAlphaDA Davidson Maintains Buy on Phreesia, Lowers Price Target to $13
BenzingaBaird Maintains Neutral on Phreesia, Raises Price Target to $11
BenzingaWhy Phreesia Stock Tumbled Today
The Motley FoolPhreesia Files Shelf Prospectus For Offering; Size Not Disclosed
BenzingaPhreesia, Inc. Q2 2027 Earnings Call Summary
MobyThese Analysts Revise Their Forecasts On Phreesia After Q2 Results
BenzingaRBC Capital Reiterates Outperform on Phreesia, Maintains $19 Price Target
BenzingaWells Fargo Maintains Equal-Weight on Phreesia, Raises Price Target to $10
BenzingaNeedham Reiterates Buy on Phreesia, Maintains $14 Price Target
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Health Information Services Stocks
Veeva Systems Inc.
$51.90B
BTSGBrightSpring Health Services, Inc.
$12.40B
TEMTempus AI, Inc.
$12.23B
HNGEHinge Health, Inc.
$9.04B
HQYHealthEquity, Inc.
$8.10B
DOCSDoximity, Inc.
$5.99B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B
















